Evidence Generation Strategy for Digital Health in Neurology

Most neurological conditions are complex diseases with no disease-modifying therapies. Neurological disease management is one of the disease areas that requires a medical approach that goes beyond the drug. All this makes neurology an area amenable to add on solutions to standardized care and practices. However, getting the proof points for the clinical and economic benefits to convince payers and physicians remains a huge challenge. The lack of disease-modifying therapies and biomarkers that objectively track disease progression makes it harder for digital health companies in the space compared to other therapeutic areas. Join HealthXL in this meeting to discuss the following: